Cargando…
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes
BACKGROUND: The current N classification, which is determined by the anatomical location of positive lymph nodes, does not effectively stratify N1 and N2 non-small cell lung cancer (NSCLC) patients into prognostically significant subgroups. METHODS: We acquired the clinical data of 3,234 N1 and N2 N...
Autores principales: | Zhou, Bolun, Zang, Ruochuan, Zhang, Moyan, Song, Peng, Liu, Lei, Bie, Fenglong, Peng, Yue, Bai, Guangyu, Gao, Shugeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459623/ https://www.ncbi.nlm.nih.gov/pubmed/36090638 http://dx.doi.org/10.21037/tlcr-21-933 |
Ejemplares similares
-
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
por: Zhou, Bolun, et al.
Publicado: (2022) -
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer
por: Zhou, Bolun, et al.
Publicado: (2022) -
Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study
por: Zhou, Bolun, et al.
Publicado: (2023) -
Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022) -
Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians
por: Bie, Fenglong, et al.
Publicado: (2021)